Alligator Bioscience AB (publ)
SSE:ATORX.ST
1.18 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Alligator Bioscience AB (publ) |
Symbool | ATORX.ST |
Munteenheid | SEK |
Prijs | 1.178 |
Beurswaarde | 775,069,812 |
Dividendpercentage | 0% |
52-weken bereik | 0.34 - 1.568 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Søren Bregenholt Ph.D. |
Website | https://www.alligatorbioscience.se |
An error occurred while fetching data.
Over Alligator Bioscience AB (publ)
Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based drugs for cancer treatment in Sweden. It develops products using its technology platforms, including ALLIGATOR-GOLD and ALLIGATOR-FAB, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)